LoI can lead to IGF-II overexpression and activate IGF-IR and AKT1 (151), leading to cancer cell proliferation and promoting progression of colorectal cancer, and overexpression of IGF-II is the main oncogenic factor in colorectal cancer (152). Here, IGF2 is linked to colorectal cancer.